DK0862577T3 - Sulfamate derivatives of 1,3,5 (10) -estratrien derivatives, process for their preparation and pharmaceutical preparations which - Google Patents

Sulfamate derivatives of 1,3,5 (10) -estratrien derivatives, process for their preparation and pharmaceutical preparations which

Info

Publication number
DK0862577T3
DK0862577T3 DK96945140T DK96945140T DK0862577T3 DK 0862577 T3 DK0862577 T3 DK 0862577T3 DK 96945140 T DK96945140 T DK 96945140T DK 96945140 T DK96945140 T DK 96945140T DK 0862577 T3 DK0862577 T3 DK 0862577T3
Authority
DK
Denmark
Prior art keywords
derivatives
preparation
pharmaceutical preparations
estratrien
sulfamate
Prior art date
Application number
DK96945140T
Other languages
Danish (da)
Inventor
Sigfrid Schwarz
Gudrun Reddersen
Birgitt Schneider
Ina Thieme
Margit Richter
Walter Elger
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Application granted granted Critical
Publication of DK0862577T3 publication Critical patent/DK0862577T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to novel sulphamate derivatives of 1,3,5(10)-estratriene derivatives of general formula (I) in which the 3-sulphamate group is acylated, sulphonated or amido-sulphonated. Also disclosed are methods of producing these compounds and pharmaceutical compounds containing them. The claimed compounds have estrogen-like properties.
DK96945140T 1995-10-19 1996-09-19 Sulfamate derivatives of 1,3,5 (10) -estratrien derivatives, process for their preparation and pharmaceutical preparations which DK0862577T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19540233A DE19540233B4 (en) 1995-10-19 1995-10-19 Sulfamate derivatives of 1,3,5 (10) estratriene derivatives, process for their preparation and pharmaceutical compositions containing them
PCT/DE1996/001823 WO1997014712A2 (en) 1995-10-19 1996-09-19 Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them

Publications (1)

Publication Number Publication Date
DK0862577T3 true DK0862577T3 (en) 1999-10-25

Family

ID=7776061

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96945140T DK0862577T3 (en) 1995-10-19 1996-09-19 Sulfamate derivatives of 1,3,5 (10) -estratrien derivatives, process for their preparation and pharmaceutical preparations which

Country Status (13)

Country Link
EP (1) EP0862577B1 (en)
JP (2) JPH11505268A (en)
KR (1) KR100306044B1 (en)
CN (1) CN1125077C (en)
AT (1) ATE178903T1 (en)
AU (1) AU1436097A (en)
BR (1) BR9610905A (en)
DE (2) DE19540233B4 (en)
DK (1) DK0862577T3 (en)
ES (1) ES2131972T3 (en)
GR (1) GR3030733T3 (en)
RU (1) RU2159774C2 (en)
WO (1) WO1997014712A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19712488A1 (en) 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroid sulfamates, processes for their preparation and use thereof
US6288050B1 (en) * 1997-07-18 2001-09-11 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
EP1085876B1 (en) * 1998-06-10 2008-07-23 Sterix Limited Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase
US6248780B1 (en) 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
DE19943708B4 (en) * 1999-09-08 2007-12-20 Bayer Schering Pharma Ag New C13-substituted Estra-1,3,5 (10) -trien-3-yl-sulfamates, processes for their preparation and pharmaceutical compositions containing them
US6583130B1 (en) 1999-09-13 2003-06-24 Schering Ag C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds
EP1769799A3 (en) * 2000-01-14 2010-01-13 Sterix Limited Pharmaceutical compositions containing steroidal structures and uses thereof
DE10027887A1 (en) * 2000-05-31 2001-12-13 Jenapharm Gmbh Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds
US8026229B2 (en) 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
DE10139494A1 (en) * 2001-08-13 2003-03-06 Jenapharm Gmbh Antitumor effective 2-alkoxyestradiol sulfamates
DE10307104A1 (en) * 2003-02-19 2004-09-23 Schering Ag Anti-tumor effective 2-substituted Estra-1,3,5 (10) -trien-3-yl sulfamate
DE10307105A1 (en) * 2003-02-19 2004-09-09 Schering Ag Antitumor active 2-substituted 18a-homoestra-1,3,5 (10) -trien-3-yl sulfamate
DE10307103A1 (en) * 2003-02-19 2004-09-09 Schering Ag Anti-tumor effective 2-substituted D-homostra-1,3,5 (10) -trien-3-yl sulfamate
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
US20080292765A1 (en) * 2007-05-22 2008-11-27 The Coca-Cola Company Sweetness Enhancers, Sweetness Enhanced Sweetener Compositions, Methods for Their Formulation, and Uses
GB201302368D0 (en) * 2013-02-11 2013-03-27 Univ Bath Compound
RU2562242C1 (en) * 2014-07-10 2015-09-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный университет" (СПбГУ) RACEMIC 2,17β-DISULFOMOYLOXY-3-METHOXY-8α-EXTRA-1,3,5(10)-TRIENE AS INHIBITOR OF TUMOUR CELL PROLIFERATION OF MCF-7

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2133484A2 (en) * 1969-04-29 1972-12-01 Jenapharm Veb 3-17 and 21-sulphonyloxy-steroids - with androgenic anabolic progestogenic and oestrogen activity of long duration
IL94183A (en) * 1989-05-05 2003-09-17 Baylor College Medicine cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE
DK0429628T3 (en) * 1989-06-16 1999-05-31 Genencor Int DNA sequences, vectors and fusion peptides to enhance secretion of desired polypeptides from filamentous fungi
JP2818056B2 (en) * 1990-09-07 1998-10-30 森永乳業株式会社 Antimicrobial peptides and antimicrobial agents
ZA932568B (en) * 1992-04-24 1993-11-12 Baylor College Midecine A Non Production of recombinant human lactoferrin

Also Published As

Publication number Publication date
DE19540233B4 (en) 2005-08-25
CN1200126A (en) 1998-11-25
DE59601683D1 (en) 1999-05-20
ES2131972T3 (en) 1999-08-01
WO1997014712A2 (en) 1997-04-24
JPH11505268A (en) 1999-05-18
GR3030733T3 (en) 1999-11-30
ATE178903T1 (en) 1999-04-15
BR9610905A (en) 1999-07-13
EP0862577B1 (en) 1999-04-14
JP3040175B2 (en) 2000-05-08
WO1997014712A3 (en) 1997-06-05
KR19990064144A (en) 1999-07-26
EP0862577A2 (en) 1998-09-09
RU2159774C2 (en) 2000-11-27
AU1436097A (en) 1997-05-07
DE19540233A1 (en) 1997-04-24
CN1125077C (en) 2003-10-22
KR100306044B1 (en) 2001-12-05

Similar Documents

Publication Publication Date Title
DK0862577T3 (en) Sulfamate derivatives of 1,3,5 (10) -estratrien derivatives, process for their preparation and pharmaceutical preparations which
DK165004C (en) SULPHAMATE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
DK0503548T3 (en) Cyclic urea derivatives, drugs containing them, and processes for their preparation.
DK165447C (en) 2-PYRIMIDINYL-1-PIPERAZINE DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND MEDICINALS CONTAINING THEM
FI901530A0 (en) Method for preparing immunomodulatory azaspiranes
HUP0001192A2 (en) The use of topiramate and its derivatives for the preparation of pharmaceutical compositions treating obesity
DK0564350T3 (en) 3,5-di-tert-butyl-4-hydroxy flavones, process for their preparation and pharmaceutical compositions having antioxidant and anti-vasoconstrictor action
EE05091B1 (en) Oligosaccharides, process for their preparation and use, and pharmaceutical compositions
DK0434057T3 (en) Indocarbazole derivatives, processes for their preparation and their use
YU9502A (en) Torsemide polymorphs
NO952205L (en) Heterocyclic carbamates, process for their preparation and medicaments
NO995431D0 (en) Substituted 3,3-diamino-2-propenitriles, their preparation and use
GR1001597B (en) Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same.
DK441180A (en) 2-HYDROXYALKYL-3,4,5-TRIHYDROXYPIPERIDINES THEIR PREPARATION AND USE
DK0906329T3 (en) 2'-Substituted nucleosides and oligonucleotide derivatives
DK0443918T3 (en) Newly-derived derivatives of 20,21-dinoreburnamenine, their preparation and use as pharmaceuticals, as well as intermediates and pharmaceutical compositions containing them
DK405884A (en) SPIRO (BENZOFURAN AZALKANES), THEIR PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
BG101722A (en) New cumarine derivatives, methods for their preparation and application
DK0552758T3 (en) N-5-Protected 2,5-diamino-4,6-dichloropyrimidines and process for their preparation
FI870873A0 (en) ISOHEXID-nucleosides.
MX9302429A (en) NEW TETRALONES, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
DK0809627T3 (en) Newborn boron oil derivatives, processes for their preparation and their pharmaceutical use
DK0427125T3 (en) Benzylselenobenzamides of anilines and benzylamines
DK0427160T3 (en) Benzylselenobenzamide of aminopyridines and picolylamines
SE8702527D0 (en) METHYLENE DERIVATIVES OF ANDROST-4-EN-3,17-DIONES AND PROCEDURE FOR THEIR PREPARATION